Abstract 7182: EZH2 inhibition as a therapeutic strategy for castration resistant prostate cancer in combination with AR-antagonist enzalutamideShikhar Sharma, Pei‐Pei Kung, Sara B. Linker et al.|Cancer Research|2025Cited by 0